Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors
Nishina, Tomohiro, Takahashi, Shunji, Iwasawa, Ryota, Noguchi, Hidehisa, Aoki, Masayuki, Doi, ToshihikoLanguage:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-017-0514-4
Date:
September, 2017
File:
PDF, 735 KB
english, 2017